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Successful management of recurrent Actinomyces esophagobronchial
fistula with self-expanding covered esophageal stent
Hyde M. Russell, MD, Alberto L. de Hoyos, MD, and Matthew G. Blum, MD, Chicago, Ill
Fistulas between the esophagus and tracheobronchialtree have been effectively managed with coveredstenting of either the esophagus or the tracheobron-chial tree. Ideally, stents for benign fistulas would
remain in the position in which they were placed and would be
easily removable after fistula closure. Unfortunately, in nonste-
notic disorders, stent migration has posed a significant prob-
lem.1 We describe the use of a new covered removable esoph-
ageal stent (Figure 1) that is designed not to migrate in the
treatment of a benign fistula.
Clinical Summary
A 59-year-old woman with diabetes and reflux had a productive
cough that persisted for several months despite treatment with
broad-spectrum antibiotic therapy. Eventually, she noticed that
her cough was associated with swallowing. Evaluation with a
bronchoscope revealed a bronchoesophageal fistula. Cultures
from the fistula biopsy specimens grew Actinomyces. The com-
munication between the bronchus intermedius and the esopha-
gus was confirmed with an esophagoscope and a barium
esophagogram. After 2 weeks of treatment with penicillin, she
underwent a right thoracotomy with division of the fistula and
interposition of an intercostal muscle flap. A postoperative
esophagogram revealed no leak or fistula, and the patient was
started on a regular diet. Her symptoms of coughing with
swallowing recurred 2 weeks later, prompting a subsequent
swallow study that confirmed recurrent fistulization (Figure 2,
A). She was referred to our institution for further management,
at which time she was unable to drink thick or thin liquids
owing to severe coughing after swallowing.
Given her recent operation and the concern for extensive
inflammation and adhesions, she was treated with a removable
esophageal stent for 6 weeks. A 22 mm  7 cm hybrid (poly-
urethane line nitinol) self-expanding stent (Alveolus, Inc, Char-
lotte, NC) was inserted under fluoroscopic guidance after lo-
calizing the fistula with a bronchoscope and esophagoscope. A
postoperative barium swallow study showed that the fistula had
been successfully excluded. The patient, however, had diffi-
culty swallowing and reported having chest and back pain after
the procedure. Two days later the stent was removed without
difficulty and replaced with an 18 mm  10 cm stent. A
percutaneous gastrostomy was placed in the same setting for
supplemental enteral feeding access. This final procedure was
well tolerated, excluded the fistula by esophagogram (Figure 2,
B), and relieved her symptoms. The patient was discharged
home on a regimen of soft foods and tube feedings. She con-
tinued penicillin treatment for actinomycosis.
Six weeks after stent placement, the patient was returned to the
operating room for stent removal. Endoscopic examination showed
the stent in good position, without migration, and the fistula
remained excluded. It was removed easily with biopsy forceps
through the flexible esophagoscope. There was a small amount of
granulation tissue in the esophagus where the distal edge of the
stent abutted the mucosa. The remainder of the esophagus was
unremarkable, and the point of prior fistualization appeared healed.
A swallow study revealed no evidence of bronchoesophageal
communication. Ten days after stent removal she reported occa-
sional slight coughing with thin liquids. An esophagogram showed
a small recurrent fistula. She was maintained on soft foods and
thick liquids. Two weeks later she noted cessation of coughing
with liquids, and an esophagogram confirmed fistula closure (Fig-
ure 2, C). Her G-tube was removed. She continues to have normal
swallowing and no symptoms of fistulization 5 months after stent
removal.
Discussion
The stent used in this case was ideally suited for this particular
patient, who required stenting for an intermediate duration (6 – 8
weeks). Excluding the fistula with an internally lined stent not
only allows for a delay of reoperation to a more favorable time
distant from the initial operation, but in this case it eliminated
a second operation altogether by allowing the fistula to close.
The Alveolus self-expanding covered stent is a new addition to
the growing set of tools available for endoscopic esophageal
interventions. The stent structure is unique in that an outer
self-expanding nitinol cage is lined on the inside by polyure-
thane. The metal tips act like scales that provide superficial
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Figure 1. Polyurethane-lined nitinol cage stent. Suture at mouth
of left (proximal) end is designed for grasping to facilitate stent
removal.
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the proximal end is designed to be grasped by biopsy forceps
for easy removal. Granulation tissue formation has been a
problem with uncovered stents and the bare metal ends of
covered stents. Laboratory studies2 and our experience suggest
that granulation tissue formation may be less of a problem with
this new stent. It is a reasonable alternative to surgical repair in
the initial treatment of acquired tracheal or bronchoesophageal
fistulas and can serve as a temporizing measure if not a defin-
itive treatment.
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Figure 2. Scan of esophagus showing esophagobronchial fistula (A), stent covering fistula (B), and esophagogram
after fistula closure (C).
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